Tag: VaxNewMo

VaxNewMo is developing next generation conjugate vaccines against bacterial diseases using its patented conjugating enzyme technology. Our conjugating enzyme technology is faster, more natural, and more reliable than methods used by pharmaceutical companies.

Learn more about VaxNewMo at www.linkedin.com/company/vaxnewmo.

A “No” from Arch Grants Isn’t a “No” to Your Business

August saw the finalist pitch day of the Arch Grants Global Startup Competition, which constitutes the final round of selection where an external panel of judges will decide who will receive...

Latest Stories

Popular Stories